| AusBiotech is pleased to deliver the ‘Pitching to Investors Masterclass’ session in Perth. We have developed a masterclass aimed at assisting leaders of life sciences companies successfully pitch to investors. The masterclass, in partnership with the Australian Securities Exchange (ASX), KPMG, Dentons (formerly DibbsBarker) and WE Buchan, is one of the three main components of the MTPConnect-funded ‘Comprehensive Global Investment Program for the Australian Life Sciences Sector’ project. The session will be facilitated by secondnature, a training consultancy that specialises in helping business professionals transform their communication and presentation abilities.
As well as founder CEOs of life sciences companies, the masterclass will be aimed at life sciences companies and researchers looking to commercialise their research. The masterclass will provide tools to prepare and develop a relevant and effective narrative for their company and product as well as improved pitching skills. All participants will be required to prepare and present a 7-minute company/product pitch during the Masterclass. Pre-workshop notes will be provided to all participants to assist with preparation for this (see below for more information).
The session is limited to 10 participants.
A subsidised rate of $150 for AusBiotech members and $250 for non-members is made possible by MTPConnect Project Funding.
If you are interested, click here to submit your EOI by 20 September 2018.
Enquiries should be directed to Dr Claretta DSouza, National Projects Manager, AusBiotech |
